Explore Cowingene’s advanced Molecular real-time PCR kit

Explore Cowingene’s advanced Molecular real-time PCR kit , 

designed for precise detection of Monkeypox, both clades Ⅰ , Ⅱ, and Ⅰb

On August 14, 2024, the WHO declared Mpox (formerly monkeypox) a Public Health Emergency of International Concern (PHEIC).

This PHEIC determination is the second in two years relating to mpox. Caused by an Orthopoxvirus, mpox was first detected in humans in 1970, in the DRC. The disease is considered endemic to countries in central and west Africa.

In July 2022, the multi-country outbreak of mpox was declared a PHEIC as it spread rapidly via sexual contact across a range of countries where the virus had not been seen before. That PHEIC was declared over in May 2023 after there had been a sustained decline in global cases.

Mpox has been reported in the DRC for more than a decade, and the number of cases reported each year has increased steadily over that period. Last year, reported cases increased significantly, and already the number of cases reported so far this year has exceeded last year’s total, with more than 15 600 cases and 537 deaths.

The emergence last year and rapid spread of a new virus strain in DRC, clade 1b, which appears to be spreading mainly through sexual networks, and its detection in countries neighbouring the DRC is especially concerning, and one of the main reasons for the declaration of the PHEIC.

In the past month, over 100 laboratory-confirmed cases of clade 1b have been reported in four countries neighbouring the DRC that have not reported mpox before: Burundi, Kenya, Rwanda and Uganda. Experts believe the true number of cases to be higher as a large proportion of clinically compatible cases have not been tested.

Cowingene is a leading developer and manufacturer of Point of Care Testing  (POCT) in vitro diagnostic reagents. The company specializes in developing and delivering rapid, convenient and accurate molecular diagnostic solutions to meet the needs of the global healthcare market.

Our monkeypox PCR kits are confirmed effective in detecting clades Ⅰ , Ⅱ and Clades Ⅰb. 

Together, let’s combat Mpox!

Learn more about our kits: